Sabine Hoff
4Patents
0h-index
24Co-inventors
31Inventor score
Filing activity: May 25, 2018 → Apr 22, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11427640B1 | CCR8 antibodies for therapeutic applications | Physics | 0 | Active |
| US11951166B2 | Combination of regorafenib and PD-1/PD-L1(2) inhibitors for treating cancer | Human Necessities | 0 | Active |
| US11517622B2 | Combination of regorafenib and PD-1/PD-L1(2) inhibitors for treating cancer | Human Necessities | 0 | Active |
| US12065497B2 | Methods of treatment using CCR8 antibodies | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.